Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Traditional Chinese medicine comprehensive therapy for acute bronchial asthma exacerbation
ChiCTR-TRC-09000464Phase 4Completed
- Sponsor
- Second Affiliated Hospital of Tianjin University of Traditional Chinese Medicine
- Start
- Sep 2007
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Small Molecules, Metabolically Activated Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial of theophylline, fluticasone propionate, salbutamol, Qinlong Zhixiao Decoction Granules, Suma Wenfei Pingxiao Decoction Granules and 1 more in asthma (3 arms), sponsored by Second Affiliated Hospital of Tianjin University of Traditional Chinese Medicine. Primary endpoints: FEV1/FVC, TCM manifestation scores and 2 more. Started Sep 2007; status: completed.
02
Drugs
theophyllinefluticasone propionatesalbutamolQinlong Zhixiao Decoction GranulesSuma Wenfei Pingxiao Decoction Granules
03
Conditions
asthma
Beyond the preview
Go deeper on ChiCTR-TRC-09000464.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR-TRC-09000464.